Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

TVTX

Travere Therapeutics, Inc.

Healthcare · USD

Set alert

Price alert · TVTX

All alert types
50.39 USD -0.18 -0.36%
As of Oct 30, 2026 Extended hours 50.39 0.00%
Bid
50.36 × 2
Ask
50.39 × 2
49.71 Day range 52.66
26.79 52-week range 67.52
YTD
+31.88%
1 year
+69.95%
Open
50.01
Prev close
50.57
Mkt cap
4.69B
Vol
1.14M
Avg vol
1.78M
EPS
-0.74
P/E
0.00
Div yield
0.00%
More statistics
Low
49.71
High
52.66
Forward P/E
9.36
Beta
1.14
Short ratio
5.59
Inst. own
116.09%
Dividend
0.00
Ex-div date
Earnings
Nov 2, 2026
50-d avg
59.34
200-d avg
46.51
1y target
75.21

5D chart

Chart tools
Interval
1m5m15m30m
TVTX five-day price chart49.250.050.751.552.2Oct 23Oct 26Oct 27Oct 28Oct 29

Financial health

Altman Z-Score

2.17 Grey zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

5 / 9 Average

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

D+1 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 1
  • P/E 1
  • P/B 1

Valuation

P/E -68.2×
FY 2016: -14.7×FY 2017: -13.7×FY 2018: -8.9×FY 2019: -4.1×FY 2020: -7.7×FY 2021: -10.3×FY 2022: -4.8×FY 2023: -6.0×FY 2024: -4.3×FY 2025: -68.2×
FY 2016 5y median -6.0× FY 2025
P/S 6.9×
FY 2016: 5.2×FY 2017: 5.3×FY 2018: 5.6×FY 2019: 3.4×FY 2020: 6.5×FY 2021: 14.1×FY 2022: 12.2×FY 2023: 4.6×FY 2024: 5.9×FY 2025: 6.9×
FY 2016 5y median 6.9× FY 2025
P/B 29.7×
FY 2016: 2.3×FY 2017: 2.8×FY 2018: 2.9×FY 2019: 2.7×FY 2020: 6.1×FY 2021: 6.1×FY 2022: 31.3×FY 2023: 3.3×FY 2024: 23.3×FY 2025: 29.7×
FY 2016 5y median 23.3× FY 2025
P/FCF -167×
FY 2016: -51.8×FY 2017: -124×FY 2018: -20.5×FY 2019: -8.1×FY 2020: -8.0×FY 2021: -47.7×FY 2022: -6.2×FY 2023: -2.1×FY 2024: -4.1×FY 2025: -167×
FY 2016 5y median -6.2× FY 2025
EV/EBITDA 164×
FY 2016: -18.1×FY 2017: -19.7×FY 2018: -14.0×FY 2019: -7.0×FY 2020: -10.0×FY 2021: -10.6×FY 2022: -5.6×FY 2023: -3.1×FY 2024: -6.5×FY 2025: 164×
FY 2016 5y median -5.6× FY 2025
EV/Sales 7.4×
FY 2016: 5.3×FY 2017: 4.9×FY 2018: 6.3×FY 2019: 4.3×FY 2020: 7.3×FY 2021: 14.8×FY 2022: 15.4×FY 2023: 7.0×FY 2024: 7.4×FY 2025: 7.4×
FY 2016 5y median 7.4× FY 2025
FCF Yield -0.6%
FY 2016: -1.9%FY 2017: -0.8%FY 2018: -4.9%FY 2019: -12.3%FY 2020: -12.5%FY 2021: -2.1%FY 2022: -16.0%FY 2023: -48.2%FY 2024: -24.6%FY 2025: -0.6%
FY 2016 5y median -16.0% FY 2025

Profitability

Gross Margin 97.9%
FY 2016: 96.6%FY 2017: 97.7%FY 2018: 96.6%FY 2019: 97.0%FY 2020: 96.9%FY 2021: 97.1%FY 2022: 96.0%FY 2023: 92.1%FY 2024: 96.7%FY 2025: 97.9%
FY 2016 5y median 96.7% FY 2025
Operating Margin -12.8%
FY 2016: -43.6%FY 2017: -34.7%FY 2018: -48.7%FY 2019: -56.9%FY 2020: -88.8%FY 2021: -151.3%FY 2022: -292.2%FY 2023: -267.2%FY 2024: -138.9%FY 2025: -12.8%
FY 2016 5y median -151.3% FY 2025
Net Margin -5.2%
FY 2016: -35.9%FY 2017: -38.6%FY 2018: -62.5%FY 2019: -83.5%FY 2020: -85.4%FY 2021: -136.6%FY 2022: -254.4%FY 2023: -76.7%FY 2024: -137.9%FY 2025: -5.2%
FY 2016 5y median -136.6% FY 2025
ROE -22.2%
FY 2016: -15.6%FY 2017: -20.4%FY 2018: -32.3%FY 2019: -66.2%FY 2020: -80.2%FY 2021: -59.6%FY 2022: -649.9%FY 2023: -55.5%FY 2024: -544.3%FY 2025: -22.2%
FY 2016 5y median -59.6% FY 2025
ROIC -13.9%
FY 2016: -11.0%FY 2017: -12.4%FY 2018: -12.8%FY 2019: -19.5%FY 2020: -30.7%FY 2021: -30.4%FY 2022: -59.8%FY 2023: -63.0%FY 2024: -69.3%FY 2025: -13.9%
FY 2016 5y median -59.8% FY 2025
ROA -4.2%
FY 2016: -9.1%FY 2017: -11.5%FY 2018: -14.5%FY 2019: -24.2%FY 2020: -27.9%FY 2021: -23.2%FY 2022: -41.4%FY 2023: -14.1%FY 2024: -54.1%FY 2025: -4.2%
FY 2016 5y median -23.2% FY 2025

Growth (YoY)

Revenue 110.5%
FY 2016: 33.7%FY 2017: 16.0%FY 2018: 6.0%FY 2019: 6.8%FY 2020: 13.1%FY 2021: -33.5%FY 2022: -17.0%FY 2023: 32.7%FY 2024: 60.5%FY 2025: 110.5%
FY 2016 FY 2025
Operating Income 80.6%
FY 2016: -14.7%FY 2017: 7.6%FY 2018: -48.8%FY 2019: -24.7%FY 2020: -76.5%FY 2021: -13.2%FY 2022: -60.4%FY 2023: -21.4%FY 2024: 16.6%FY 2025: 80.6%
FY 2016 FY 2025
EPS (diluted) 86.3%
FY 2016: -139.4%FY 2017: -23.2%FY 2018: -64.9%FY 2019: -36.2%FY 2020: -2.9%FY 2021: 15.4%FY 2022: -45.2%FY 2023: 65.7%FY 2024: -172.0%FY 2025: 86.3%
FY 2016 FY 2025
Free Cash Flow 94.0%
FY 2016: -78.3%FY 2017: 51.1%FY 2018: -576.0%FY 2019: -65.2%FY 2020: -120.4%FY 2021: 76.0%FY 2022: -451.2%FY 2023: -49.8%FY 2024: -5.3%FY 2025: 94.0%
FY 2016 FY 2025

Financial Health

Current Ratio 2.7×
FY 2016: 4.0×FY 2017: 3.8×FY 2018: 4.7×FY 2019: 4.5×FY 2020: 4.4×FY 2021: 4.7×FY 2022: 3.4×FY 2023: 3.5×FY 2024: 2.1×FY 2025: 2.7×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 2.7×
FY 2016: 4.0×FY 2017: 3.7×FY 2018: 4.7×FY 2019: 4.4×FY 2020: 4.3×FY 2021: 4.6×FY 2022: 3.4×FY 2023: 3.4×FY 2024: 2.0×FY 2025: 2.7×
FY 2016 5y median 3.4× FY 2025
Debt / Equity 2.9×
FY 2016: 0.1×FY 2017: 0.2×FY 2018: 0.7×FY 2019: 1.0×FY 2020: 1.2×FY 2021: 0.9×FY 2022: 9.5×FY 2023: 2.0×FY 2024: 6.8×FY 2025: 2.9×
FY 2016 5y median 2.9× FY 2025
Net Debt / EBITDA 10.6×
FY 2016: -0.1×FY 2017: 1.4×FY 2018: -1.6×FY 2019: -1.4×FY 2020: -1.1×FY 2021: -0.5×FY 2022: -1.2×FY 2023: -1.1×FY 2024: -1.3×FY 2025: 10.6×
FY 2016 5y median -1.1× FY 2025
Interest Coverage -5.8×
FY 2016: -12.3×FY 2017: -12.2×FY 2018: -8.2×FY 2019: -5.3×FY 2020: -9.2×FY 2021: -10.1×FY 2022: -29.0×FY 2023: -34.2×FY 2024: -29.0×FY 2025: -5.8×
FY 2016 5y median -29.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31